XML 66 R60.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies - FY thru Revenue (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Jan. 01, 2020
item
Feb. 29, 2020
USD ($)
Nov. 30, 2019
USD ($)
Aug. 31, 2019
USD ($)
Jun. 01, 2019
USD ($)
Mar. 02, 2019
USD ($)
Dec. 01, 2018
USD ($)
Sep. 01, 2018
USD ($)
Jun. 02, 2018
USD ($)
Feb. 29, 2020
USD ($)
Mar. 02, 2019
USD ($)
Mar. 03, 2018
USD ($)
Fiscal Year                        
Length of reporting period                   364 days 364 days 364 days
Deferred Financing Costs                        
Amortization expenses of deferred financing costs                   $ 10,187 $ 10,761 $ 8,403
Revenue Recognition                        
Number of points for Gold status | item 500                      
Measurement period 6 months                      
Percentage discount on qualifying purchases of front end merchandise on achieving "Gold" tier 20.00%                      
Total revenue   $ 5,727,242 $ 5,462,298 $ 5,366,264 $ 5,372,589 $ 5,379,645 $ 5,450,060 $ 5,421,362 $ 5,388,490 21,928,393 21,639,557 21,528,968
Intersegment elimination                        
Revenue Recognition                        
Total revenue                   (247,353) (211,283) (200,326)
Retail Pharmacy                        
Revenue Recognition                        
Accrued contract liabilities   52,668       63,720       52,668 63,720  
Accrued contract liabilities included in other current liabilities   52,668       51,042       52,668 51,042  
Accrued contract liabilities included in noncurrent liabilities   $ 0       $ 12,678       0 12,678  
Other revenue                   146,917 150,461 155,636
Total revenue                   15,616,186 15,757,152 15,832,625
Pharmacy sales                        
Revenue Recognition                        
Revenue from contract with customer                   10,354,293 10,391,539 10,328,376
Front end sales                        
Revenue Recognition                        
Revenue from contract with customer                   5,114,976 5,215,152 5,348,613
Pharmacy Services                        
Revenue Recognition                        
Total revenue                   $ 6,559,560 6,093,688 5,896,669
Prescription files                        
Intangible Assets                        
Estimated useful life, acquired assets                   10 years    
Estimated useful life of purchased prescription files acquired in other than business combinations                   5 years    
Trade names                        
Intangible Assets                        
Estimated useful life of purchased prescription files acquired in other than business combinations                   10 years    
CMS license                        
Intangible Assets                        
Estimated useful life of purchased prescription files acquired in other than business combinations                   25 years    
Minimum | Customer relationships                        
Intangible Assets                        
Estimated useful life, acquired assets                   10 years    
Maximum | Customer relationships                        
Intangible Assets                        
Estimated useful life, acquired assets                   20 years    
Buildings | Minimum                        
Fiscal Year                        
Useful life                   30 years    
Buildings | Maximum                        
Fiscal Year                        
Useful life                   45 years    
Equipment | Minimum                        
Fiscal Year                        
Useful life                   3 years    
Equipment | Maximum                        
Fiscal Year                        
Useful life                   15 years    
Internal-use software                        
Fiscal Year                        
Capitalized costs                   $ 15,240 $ 13,716 $ 13,940
Rite Aid Subsidiaries [Member]                        
Fiscal Year                        
Ownership interest (as a percent)   100.00%               100.00%